Akorn gets U.S. approval to buy Hi-Tech Pharmacal, with conditions
April 14, 2014 at 17:35 PM EDT
WASHINGTON, April 14 (Reuters) - Generic drugmaker Akorn Enterprises Inc has won U.S. antitrust approval to buy rival Hi-Tech Pharmacal Inc on condition that it sell three generic prescription eye medications and two generic topical anesthetics, the Federal Trade Commission said on Monday.
